Overview

Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
A randomised, double-blind, multi-centre study to evaluate the efficacy and safety of two doses of inhaled fluticasone furoate in the treatment of persistent asthma in adults and adolescents currently receiving mid to high strength inhaled corticosteroids.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Albuterol
Fluticasone
Xhance